[Determination of prognostic factors in incidental XXXX ].

@entity1 @entity263 @entity5 @entity1067 @entity1151 @entity3
Over a ten year period, 5,954 @entity1 with @entity1067 ( @entity1067 ) were hospitalized in our Institution. Of these, 1,000 cases were randomly chosen for the present study. Surgery was performed in 930 @entity1 : transurethral resection (TUR) in 665 (72%) and open prostatectomy in 265 (28%). The pathological analyses revealed @entity263 in 36 @entity1 (4%). Seven @entity1 were excluded: 5 due to a short follow-up (less than one year), one who had died from @entity1151 immediately postoperatively and one who had developed @entity3 a few months after the operation. The age of the 29 evaluable @entity1 ranged from 53 to 91 years (mean 72.7 years) and the overall mean follow-up was 43 months. Eighteen @entity1 staged A1 were treated conservatively and followed from 12 to 127 months (mean 53.5 months). Two @entity1 (11%) showed progression, one locally at 42 months (5.5%) and one developed bone @entity3 at 15 months (5.5%) and died at 27 months (Mortality: 5.5%). Of the eleven @entity1 with stage A2 @entity263 , 7 were managed conservatively (watchful waiting), 1 underwent radical prostatectomy and 3 received early hormone therapy for undifferentiated lesions. Five @entity1 progressed (45%), including the three @entity1 treated with early hormone therapy, 3 local (27%) and 2 systemic (18%). Two of the 11 @entity1 died from @entity5 (18%) and 2 from unrelated causes. The Gleason grading system and @entity5 volume (focal or diffuse) were compared as prognostic factors using the Kaplan-Meyer and log-rank test.(ABSTRACT TRUNCATED AT 250 WORDS)
